Thus, it was hypothesised that rather than increasing ALS or FTD risk directly, the SNPs act by potentiating the expression of a cryptic exon which is dependent on TDP-43 depletion. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.